Pular para o conteúdo principal
Ranking Invest

CAPR - Capricor Therapeutics, Inc.

Segmento: HealthcareCapricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Phase II clinical trial for the treatment of cytokine storm associated with SARS-CoV-2. The company also develops CAP-2003 that is in pre-clinical development for the treatment of trauma related injuries and conditions; and two vaccine candidates, which are in development stage for the potential prevention of COVID-19. It collaborates with Lonza Houston, Inc. for the clinical manufacturing of CAP-1002, its cell therapy candidate for the treatment of DMD and other indications. The company was founded in 2005 and is headquartered in San Diego, California.

Análise Ranking Invest

Valuation estimado
$ 6.02 Mi
Valor de Mercado
$ 486.91 Mi
Sobrepreço (AV)+7983.1%
IVR
0.01A companhia vale 0,01 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
-0.50O valuation alternativo equivale a -50% do valor de mercado da companhia.
MLL
-0.50O lucro líquido dos controladores em 16 trimestres equivale a -50% do valor de mercado.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 246.22 Mi

Dívida Líquida

-$ 20.94 Mi

L4T

-$ 129.42 Mi

Indicadores Básicos

ROE

-52.56%

Índices de Previsibilidade

Receita Líquida

G0.91

Lucro

E1.27

Margem

D0.81

Índices de Tendência

Receita Líquida

E-4.16

Lucro

G-10.46

Margem

B7.75

Índices de Endividamento

DIV/PAT

-0.09

DIV/L4T

0.16

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.